Back to LLY
BROWN BROTHERS HARRIMAN & CO → LLY
BROWN BROTHERS HARRIMAN & CO LLY Position History
Eli Lilly and Company • Healthcare
Quarters held
4
Latest value
$318M
Q3 2026
Peak value
$330.3M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $198M |
| Q1 2026 | $225.9M |
| Q2 2026 | $330.3M |
| Q3 2026 | $318M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $318M | 274.8K | — | — |
| Q2 2026 | $330.3M | 275.4K | — | — |
| Q1 2026 | $225.9M | 245.6K | — | — |
| Q4 2025 | $198M | 184.2K | — | — |
Other funds holding LLY
$108.4B
$104.2B
$99.1B
$84.5B
$79.5B
$72.9B